Dr. Jeffrey R. Jay, M.D. as of Sept. 30, 2012
Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D. holds 30 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zogenix | 11.9 | $15M | 5.8M | 2.64 | |
| Questcor Pharmaceuticals | 8.7 | $11M | 600k | 18.47 | |
| OncoGenex Pharmaceuticals | 8.0 | $10M | 721k | 14.17 | |
| China Kanghui Holdings | 7.7 | $9.8M | 324k | 30.35 | |
| Oncothyreon | 7.4 | $9.4M | 1.8M | 5.13 | |
| Hyperion Therapeutics | 6.3 | $8.0M | 750k | 10.63 | |
| Insulet Corporation (PODD) | 5.2 | $6.7M | 309k | 21.58 | |
| Rigel Pharmaceuticals | 4.8 | $6.1M | 592k | 10.24 | |
| D Horizon Pharma | 4.5 | $5.7M | 1.6M | 3.50 | |
| Vanda Pharmaceuticals (VNDA) | 4.5 | $5.7M | 1.4M | 4.03 | |
| Biodel | 3.1 | $4.0M | 1.4M | 2.97 | |
| Pain Therapeutics | 3.1 | $3.9M | 780k | 5.05 | |
| NPS Pharmaceuticals | 2.9 | $3.7M | 400k | 9.25 | |
| Targacept | 2.8 | $3.5M | 721k | 4.89 | |
| Nektar Therapeutics (NKTR) | 2.7 | $3.4M | 320k | 10.67 | |
| Amarin Corporation (AMRN) | 2.0 | $2.6M | 204k | 12.57 | |
| Palatin Technologies | 1.8 | $2.2M | 3.2M | 0.69 | |
| RTI Biologics | 1.6 | $2.1M | 500k | 4.18 | |
| Furiex Pharmaceuticals | 1.6 | $2.0M | 105k | 19.08 | |
| INC Ventrus Biosciences | 1.5 | $1.9M | 539k | 3.58 | |
| Synergetics USA | 1.3 | $1.6M | 325k | 4.94 | |
| Columbia Laboratories | 1.2 | $1.5M | 1.5M | 0.99 | |
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $1.5M | 600k | 2.53 | |
| Spectranetics Corporation | 1.2 | $1.5M | 100k | 14.75 | |
| Vascular Solutions | 1.1 | $1.4M | 97k | 14.80 | |
| Cardica | 0.8 | $1.0M | 695k | 1.44 | |
| Alphatec Holdings | 0.8 | $990k | 600k | 1.65 | |
| Dex (DXCM) | 0.3 | $376k | 25k | 15.04 | |
| Tengion | 0.1 | $122k | 90k | 1.35 | |
| AMAG Pharmaceuticals | 0.0 | $3.0k | 150.00 | 20.00 |
